FALCO HOLDINGS Co., Ltd. (4671.T)
JPY 2282.0
(-0.26%)
JPY 2282.0
(-0.26%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 10.77 Billion JPY | -8.69% |
| 2022 | 11.56 Billion JPY | -2.19% |
| 2021 | 11.82 Billion JPY | 6.71% |
| 2020 | 11.08 Billion JPY | -3.59% |
| 2019 | 11.49 Billion JPY | 0.52% |
| 2018 | 11.43 Billion JPY | -0.31% |
| 2017 | 11.47 Billion JPY | -0.92% |
| 2016 | 11.57 Billion JPY | -5.33% |
| 2015 | 12.23 Billion JPY | 3.22% |
| 2014 | 11.84 Billion JPY | -17.53% |
| 2013 | 14.36 Billion JPY | -5.24% |
| 2012 | 15.16 Billion JPY | 3.01% |
| 2011 | 14.71 Billion JPY | 1.82% |
| 2010 | 14.45 Billion JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 10.77 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.83 Billion JPY | 13.58% |
| 2023 Q4 | 2.49 Billion JPY | -6.76% |
| 2023 Q3 | 2.67 Billion JPY | -2.01% |
| 2023 Q2 | 2.73 Billion JPY | -4.31% |
| 2023 Q1 | 2.85 Billion JPY | 3.1% |
| 2023 FY | 10.56 Billion JPY | -8.69% |
| 2022 FY | 11.56 Billion JPY | -2.19% |
| 2022 Q3 | 2.87 Billion JPY | -3.81% |
| 2022 Q1 | 2.92 Billion JPY | -8.1% |
| 2022 Q2 | 2.99 Billion JPY | 2.19% |
| 2022 Q4 | 2.77 Billion JPY | -3.75% |
| 2021 Q3 | 2.95 Billion JPY | 5.98% |
| 2021 Q1 | 2.89 Billion JPY | 2.12% |
| 2021 FY | 11.82 Billion JPY | 6.71% |
| 2021 Q2 | 2.79 Billion JPY | -3.49% |
| 2021 Q4 | 3.18 Billion JPY | 7.71% |
| 2020 Q3 | 2.82 Billion JPY | 7.49% |
| 2020 Q2 | 2.63 Billion JPY | -5.77% |
| 2020 Q4 | 2.83 Billion JPY | 0.14% |
| 2020 FY | 11.08 Billion JPY | -3.59% |
| 2020 Q1 | 2.79 Billion JPY | -1.17% |
| 2019 Q3 | 2.99 Billion JPY | 6.98% |
| 2019 Q1 | 2.88 Billion JPY | 4.34% |
| 2019 FY | 11.49 Billion JPY | 0.52% |
| 2019 Q4 | 2.82 Billion JPY | -5.52% |
| 2019 Q2 | 2.79 Billion JPY | -3.15% |
| 2018 Q3 | 2.87 Billion JPY | 1.84% |
| 2018 FY | 11.43 Billion JPY | -0.31% |
| 2018 Q4 | 2.76 Billion JPY | -3.79% |
| 2018 Q2 | 2.82 Billion JPY | -5.01% |
| 2018 Q1 | 2.97 Billion JPY | 9.39% |
| 2017 Q4 | 2.71 Billion JPY | -8.49% |
| 2017 Q1 | 2.99 Billion JPY | 11.29% |
| 2017 Q3 | 2.96 Billion JPY | 6.42% |
| 2017 Q2 | 2.79 Billion JPY | -6.88% |
| 2017 FY | 11.47 Billion JPY | -0.92% |
| 2016 Q4 | 2.69 Billion JPY | -7.65% |
| 2016 Q2 | 2.88 Billion JPY | -6.42% |
| 2016 Q3 | 2.91 Billion JPY | 0.97% |
| 2016 Q1 | 3.08 Billion JPY | 4.93% |
| 2016 FY | 11.57 Billion JPY | -5.33% |
| 2015 Q1 | 3.08 Billion JPY | 7.34% |
| 2015 Q3 | 3.16 Billion JPY | 4.11% |
| 2015 Q2 | 3.04 Billion JPY | -1.39% |
| 2015 FY | 12.23 Billion JPY | 3.22% |
| 2015 Q4 | 2.94 Billion JPY | -7.14% |
| 2014 Q3 | 2.98 Billion JPY | 1.29% |
| 2014 Q4 | 2.87 Billion JPY | -3.66% |
| 2014 FY | 11.84 Billion JPY | -17.53% |
| 2014 Q1 | 3.05 Billion JPY | -0.85% |
| 2014 Q2 | 2.94 Billion JPY | -3.48% |
| 2013 Q2 | 3.71 Billion JPY | -1.01% |
| 2013 FY | 14.36 Billion JPY | -5.24% |
| 2013 Q1 | 3.75 Billion JPY | -9.63% |
| 2013 Q3 | 3.82 Billion JPY | 2.93% |
| 2013 Q4 | 3.07 Billion JPY | -19.56% |
| 2012 Q3 | 3.65 Billion JPY | 1.14% |
| 2012 FY | 15.16 Billion JPY | 3.01% |
| 2012 Q2 | 3.61 Billion JPY | -3.6% |
| 2012 Q1 | 3.74 Billion JPY | 5.02% |
| 2012 Q4 | 4.15 Billion JPY | 13.72% |
| 2011 FY | 14.71 Billion JPY | 1.82% |
| 2011 Q2 | 3.68 Billion JPY | -2.79% |
| 2011 Q4 | 3.56 Billion JPY | -2.81% |
| 2011 Q3 | 3.67 Billion JPY | -0.49% |
| 2011 Q1 | 3.79 Billion JPY | 6.66% |
| 2010 FY | 14.45 Billion JPY | 0.0% |
| 2010 Q3 | 3.6 Billion JPY | 1.23% |
| 2010 Q2 | 3.56 Billion JPY | -4.27% |
| 2010 Q1 | 3.72 Billion JPY | 0.0% |
| 2010 Q4 | 3.55 Billion JPY | -1.44% |
| 2009 Q3 | 2.65 Billion JPY | 0.0% |
| 2009 FY | - JPY | -100.0% |
| 2009 Q4 | - JPY | -100.0% |
| 2008 Q3 | 2.77 Billion JPY | 0.0% |
| 2008 Q4 | 2.51 Billion JPY | -9.48% |
| 2008 FY | 10.77 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 9.85 Billion JPY | -9.252% |
| DNA Chip Research Inc. | 324.19 Million JPY | -3222.373% |
| Cosmo Bio Company,Limited | 2.73 Billion JPY | -294.398% |
| H.U. Group Holdings, Inc. | 67.27 Billion JPY | 83.99% |
| BML, Inc. | 36.46 Billion JPY | 70.459% |
| Human Metabolome Technologies, Inc. | 639.4 Million JPY | -1584.543% |
| Precision System Science Co., Ltd. | 1.9 Billion JPY | -464.926% |